Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stille ABOSTO:STIL -0.42%100 EV-to-OCF is 33.59 as of Aug. 15, 2026, which is 43% above its 10-year median of 23.55. GuruFocus rates OSTO:STIL with a GF Score™ of 100/100 and a GF Value™ of kr257.67 (Fairly Valued). The stock has 1 warning sign investors should review. Among 853 Medical Devices & Instruments companies, Stille AB ranks worse than 84.76% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Stille AB's Enterprise Value is kr2,152.1 Mil.
Stille AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was kr64.1 Mil. Therefore, Stille AB's EV-to-OCF for today is 33.59.
The historical rank and industry rank for Stille AB's EV-to-OCF or its related term are showing as below:
OSTO:STIL'
s EV-to-OCF Range Over the Past 10 Years
Min: 7.5 Med: 23.55 Max: 148.56
Current: 32.89
During the past 13 years, the highest EV-to-OCF of Stille AB was 148.56. The lowest was 7.50. And the median was 23.55.
OSTO:STIL's EV-to-OCF is ranked worse than 84.76% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.94
vs OSTO:STIL: 32.89
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Stille AB's share price for today is kr239.00.
Stille AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr8.090.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Stille AB EV-to-OCF Related Terms
Stille AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Stille AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:STIL vs ISRG, BDX, MDLN: EV-to-OCF Comparison
For the Medical Instruments & Supplies subindustry, Stille AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stille AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stille AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Stille AB's EV-to-OCF falls into.
Stille AB's current Enterprise Value is kr2,152.1 Mil.
Stille AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr64.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stille AB (OSTO:STIL) has a EV-to-OCF of 33.59 as of Aug. 15, 2026. This is 43% above median its historical median of 23.55. Over the past decade, Stille AB's EV-to-OCF has ranged from 7.50 to 148.56. According to the industry distribution chart, Stille AB ranks #723 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 84.8%.
Is Stille AB's EV-to-OCF too high?
Stille AB's current EV-to-OCF of 33.59 is 43% above median its 10-year median of 23.55. Over the past 10 years, this metric has ranged from a low of 7.50 to a high of 148.56. The Medical Devices & Instruments industry median EV-to-OCF is 7.94. Stille AB's value of 33.59 is 323% above this industry median. Based on the distribution chart, Stille AB ranks #723 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Stille AB has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Stille AB's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Stille AB ranks #723 out of 853 companies for EV-to-OCF. This places Stille AB in the lower half of its industry. The industry median EV-to-OCF is 7.94. Stille AB's value of 33.59 is 323% above this benchmark. Historically, Stille AB's own EV-to-OCF has ranged from 7.50 to 148.56 over the past decade. While the company's 10-year median is 23.55 vs. the industry median of 7.94, Stille AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.94, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stille AB's current EV-to-OCF of 33.59 is 323% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stille AB's current EV-to-OCF is 33.59, which is 43% above median its own 10-year median of 23.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stille AB stock overvalued right now?
Based on GuruFocus' analysis, Stille AB (OSTO:STIL) is currently considered Fairly Valued. The stock's GF Value™ is kr257.67, compared to a current price of kr239.00 — trading 7.2% below its estimated fair value. The current EV-to-OCF is 33.59, which is 43% above median its 10-year median of 23.55 and 323% above the Medical Devices & Instruments industry median of 7.94. Stille AB's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Stille AB (OSTO:STIL), the current EV-to-OCF is 33.59 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stille AB (OSTO:STIL) Overvalued in 2026?
Based on GuruFocus' analysis, Stille AB stock appears to be undervalued.
The current stock price of kr239.00 is trading 7.2% below its estimated GF Value™ of kr257.67.
GuruFocus considers Stille AB to be Fairly Valued.
Key valuation signals for OSTO:STIL:
EV-to-OCF: 33.59 (43% above median its 10-year median of 23.55)
GF Value™: kr257.67 vs. price of kr239.00 (7.2% below fair value)
Industry Position: 323% above the Medical Devices & Instruments median (#723 of 853)
No single metric tells the full story. See the OSTO:STIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
100GF Score
Get the complete analysis for OSTO:STIL
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:STIL has been successfully added to your 
